Vaxcell-Bio Therapeutics Logo

Vaxcell-Bio Therapeutics

Biotech firm developing immunotherapies for oncology and other diseases.

323990 | KO

Overview

Corporate Details

ISIN(s):
KR7323990002
LEI:
Country:
South Korea
Address:
전라남도 화순군 화순읍 산단길 12-55, 화순군

Description

Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of innovative immunotherapies. The company's primary focus is on oncology, developing a pipeline of cell-based and protein-based treatments, including immune cell therapies and targeted protein-degrading therapeutics. In addition to its core focus on cancer, Vaxcell-Bio is expanding its research into other areas, such as developing drug delivery system (DDS)-based therapies for conditions like macular degeneration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-09-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.8 KB
2023-09-26 00:00
[기재정정]증권신고서(지분증권) (2023.10)
Korean 1.8 MB
2023-09-26 00:00
[기재정정]투자설명서
Korean 1.7 MB
2023-09-19 00:00
유상증자1차발행가액결정
Korean 7.8 KB
2023-09-19 00:00
[발행조건확정]증권신고서(지분증권)
Korean 102.1 KB
2023-09-19 00:00
[기재정정]주요사항보고서(유무상증자결정)
Korean 42.7 KB
2023-09-19 00:00
[기재정정]투자설명서
Korean 1.8 MB
2023-09-19 00:00
권리락(유상증자)
Korean 3.5 KB
2023-09-06 00:00
투자설명서
Korean 1.7 MB
2023-09-04 00:00
[기재정정]증권신고서(지분증권) (2023.10)
Korean 1.9 MB
2023-08-21 00:00
[기재정정]증권신고서(지분증권) (2023.10)
Korean 2.2 MB
2023-08-14 00:00
반기보고서 (2023.06)
Korean 865.9 KB
2023-08-07 00:00
주권매매거래정지(무상증자)
Korean 4.7 KB
2023-08-07 00:00
주요사항보고서(유무상증자결정)
Korean 40.5 KB
2023-08-07 00:00
증권신고서(지분증권) (2023.10)
Korean 1.6 MB

Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vaxcell-Bio Therapeutics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.